62 RGT075 RGT075 is a small oral GLP-1RA identified through Computer-Accelerated Rational Design (CARD) with potent G-protein-coupled cAMP signaling
BPC-157 drives blood vessel formation and growth factor signaling different axis entirely
What Is the Glycemic Index, and Why Should Diabetics Care
Notable Investors: Frazier Life Sciences, Balyasny Asset Management, Citadel Advisors, Janus Henderson Investors, and The Vanguard Group Key Products: Lexeo Therapeutics is developing LX2006, a gene therapy for Friedreichs ataxia cardiomyopathy
GLP-1 receptor agonists are biological protein medications requiring refrigeration at 28C to maintain stability and therapeutic efficacy
Teskey, G., et al., Glutathione as a Marker for Human Disease